INTRODUCTIONAcne vulgaris is a chronic inflammatory disease that affects pilosebaceous units on the face and trunk requiring longitudinal patient management.1,2 It has a multifactorial pathophysiology that involves an altered sebaceous…
Read More
INTRODUCTIONA member of the tyrosine-protein kinase Tec (TEC) family of tyrosine kinases, Bruton tyrosine kinase (BTK) is a cytoplasmic, nonreceptor kinase essential to myriad immunological pathways.1 Activity of BTK most…
Read More
INTRODUCTION Challenging body areas include the scalp, face, palmoplantar surfaces (ie, palms and soles), nails, intertriginous areas, and genitalia. Psoriasis involving challenging body areas is associated with a higher degree…
Read More
INTRODUCTIONPlaque psoriasis is a chronic, relapsing systemic illness that has a significant effect on quality of life.1-3 New biologic therapies targeting tumor necrosis factor (TNF), interleukin (IL)-12/23, IL-17, and IL-23…
Read More
INTRODUCTIONPsoriasis is a chronic inflammatory disorder primarily affecting the skin and joints. It affects different racial/ethnic groups worldwide with varying prevalence. Although psoriasis has historically been considered to predominately affect…
Read More
INTRODUCTIONNarrow band-ultraviolet B (NB-UVB) light therapy has been shown to be one of the safest, least expensive, and most effective treatments for psoriasis.1 Traditional clinic-based phototherapy is time-consuming, expensive, and…
Read More
INTRODUCTIONMelanoma accounts for only 1% of all skin cancers but is responsible for most skin cancer-related deaths.1 Acral and mucosal melanoma (AMM) accounts for only 4% of all new melanomas…
Read More
INTRODUCTIONAtopic dermatitis (AD), commonly known as eczema, is a common chronic inflammatory skin condition, characterized by dry, itchy skin, making individuals more susceptible to skin infections and other complications.1 This…
Read More
INTRODUCTIONThe combined use of topical calcipotriol/betamethasone dipropionate (Cal/BDP) is commonly used and demonstrated to be effective for the management of psoriasis. Used in combination, topical calcipotriol, and betamethasone dipropionate confer…
Read More
INTRODUCTIONPsoriasis is a chronic inflammatory skin disease that affects nearly 8 million adults in the United States (US).1 The disease is characterized by sharply demarcated, scaly, erythematous plaques that can…
Read More
INTRODUCTIONSome psoriatic disease topical treatments, such as coal tar and salicylic acid, have stood the test of time, being used consistently over the past century.1 However, the landscape of systemic…
Read More
INTRODUCTIONPsoriasis is a chronic inflammatory disorder affecting up to 2% to 4% of the general population worldwide.1 The treatment of moderate-to-severe psoriasis includes systemic disease-modifying antirheumatic drugs (DMARDs), such as…
Read More
